ISPC
iSpecimen Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
iSpecimen Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
0
filed ties
13F top-10 QoQ
Top fund weight
—
iSpecimen Inc.
0.82
−0.02 · −1.95%
post 0.83 +2.21%
−52.73%
shares held · 5 largest managers
No changes.
No changes.
| Manager | Value | % base | |
|---|---|---|---|
| UBS | $84,898 | 56.23% | −40.39% |
| Jane Street | $64,697 | 42.85% | −56.11% |
| Tower Research Capital LLC (TRC) | $580 | 0.38% | −96.71% |
| IFP | $530 | 0.35% | new |
| BlackRockindex-like | $188 | 0.12% | −97.49% |
| Manager | Value | % base | |
|---|---|---|---|
| UBS | $84,898 | 56.23% | −40.39% |
| Jane Street | $64,697 | 42.85% | −56.11% |
| Tower Research Capital LLC (TRC) | $580 | 0.38% | −96.71% |
| IFP | $530 | 0.35% | new |
| BlackRockindex-like | $188 | 0.12% | −97.49% |
Same SIC code · 6
Same SEC industry code: Iqvia Holdings Inc., Incyte Corp, Charles River Laboratories International, Inc. and 3 more; no measured co-movers for iSpecimen Inc..
Same SIC code · 6
Same SEC industry code: Iqvia Holdings Inc., Incyte Corp, Charles River Laboratories International, Inc. and 3 more; no measured co-movers for iSpecimen Inc..
Annual filing, covered
10-K parsed · Apr 1 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Apr 1 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Tall tick = annual report · Source: EDGAR
No thesis.
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Expected move
No implied move.